Patrick Y. Wen focuses on Internal medicine, Oncology, Glioma, Surgery and Clinical trial. His research combines Brain tumor and Internal medicine. His studies in Oncology integrate themes in fields like Incidence, Cediranib, Temozolomide, Tumor progression and Pharmacology.
His Glioma research is multidisciplinary, relying on both Neoplasm Grading, Chemotherapy regimen, Progression-free survival and Pathology. Patrick Y. Wen has included themes like Gastroenterology and Hazard ratio in his Surgery study. The various areas that Patrick Y. Wen examines in his Clinical trial study include Randomized controlled trial, Intensive care medicine, Pseudoprogression, Glioblastoma and Response assessment.
Patrick Y. Wen mostly deals with Internal medicine, Oncology, Glioma, Surgery and Cancer research. In his work, Newly diagnosed is strongly intertwined with Glioblastoma, which is a subfield of Internal medicine. His Oncology research is multidisciplinary, incorporating elements of Cancer, Clinical trial, Pathology and Chemotherapy.
The concepts of his Clinical trial study are interwoven with issues in Brain tumor and Intensive care medicine. His Glioma research includes elements of Pharmacokinetics, Pharmacology, Angiogenesis and Mutant, IDH1. Surgery is closely attributed to Gastroenterology in his work.
Patrick Y. Wen mainly focuses on Internal medicine, Oncology, Cancer research, Glioma and Glioblastoma. His study in Internal medicine focuses on Bevacizumab, Recurrent glioblastoma, Progression-free survival, Phases of clinical research and Clinical trial. His Clinical trial research integrates issues from Neurologic Oncology, Response assessment and Intensive care medicine.
His study on Oncology also encompasses disciplines like
His primary areas of investigation include Internal medicine, Oncology, Clinical trial, Glioma and Cancer research. As part of his studies on Internal medicine, he frequently links adjacent subjects like Gastroenterology. His study in Oncology is interdisciplinary in nature, drawing from both Survival rate, Radiation therapy, Glioblastoma, Temozolomide and Biomarker.
His research on Clinical trial also deals with topics like
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Malignant Gliomas in Adults
Patrick Y Wen;Santosh Kesari.
The New England Journal of Medicine (2008)
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
Patrick Y. Wen;David R. Macdonald;David A. Reardon;Timothy F. Cloughesy.
Journal of Clinical Oncology (2010)
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
Henry S. Friedman;Michael D. Prados;Patrick Y. Wen;Tom Mikkelsen.
Journal of Clinical Oncology (2009)
AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients
Tracy T. Batchelor;A. Gregory Sorensen;A. Gregory Sorensen;Emmanuelle di Tomaso;Wei Ting Zhang;Wei Ting Zhang.
Cancer Cell (2007)
Exciting New Advances in Neuro-Oncology The Avenue to a Cure for Malignant Glioma
Erwin Van Meir;Constantinos G Hadjipanayis;Andrew D. Norden;Hui-Kuo Shu.
CA: A Cancer Journal for Clinicians (2010)
Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence.
A. D. Norden;G. S. Young;K. Setayesh;A. Muzikansky.
Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors Report of the Quality Standards Subcommittee of the American Academy of Neurology
M. J. Glantz;B. F. Cole;B. F. Cole;P. A. Forsyth;L. D. Recht;L. D. Recht.
Epidemiology of Brain Metastases
Lakshmi Nayak;Eudocia Quant Lee;Patrick Y. Wen.
Current Oncology Reports (2012)
Stereotactic Radiosurgery for the Definitive, Noninvasive Treatment of Brain Metastases
Eben Alexander;Thomas M. Moriarty;Roger B. Davis;Patrick Y. Wen.
Journal of the National Cancer Institute (1995)
Frequency, Characteristics, and Reversibility of Peripheral Neuropathy During Treatment of Advanced Multiple Myeloma With Bortezomib
Paul G. Richardson;Hannah Briemberg;Sundar Jagannath;Patrick Y. Wen.
Journal of Clinical Oncology (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: